MED ENG PHYS 润色咨询

MEDICAL ENGINEERING & PHYSICS

出版年份：1994 年文章数：3334 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：6.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1094996, encodeId=198e1094996f1, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094995, encodeId=8fb51094995bf, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901370, encodeId=78019013e023, content=审稿速度:2.0<br>偏重的研究方向：生物医学工程<br>经验分享：发表几十篇SCI，但这个期刊是印象最不好的，原因如下：<br>从投稿到收到收到最终决定大约两个多月，稿件显示状态一直是"Decision in Process"。<br>最终只得到了拒稿信，没有任何的评审意见。<br>如果是编委觉得稿件不合适，可以用几天，甚至半个月的时间告知作者不适合期刊定位及质量要求，这样不耽误作者转投其它期刊；<br>如果是已经送审，最终连评审意见都不反馈很不专业。<br><br>建议大家还是考虑MP或者PMB，如果被拒，说明文章创新点不够，那么索性就投个三四区一般的期刊，但这个期刊还是要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d382492015, createdName=兰德, createdTime=Mon Nov 23 10:13:54 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512205, encodeId=b210512205d0, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：三个审稿者，一个给了大修，一个给了小修，一个同意直接接收，但要求把文章类型作改为communication。呵呵，不知道机会大不大!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Mon Jun 01 14:16:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512001, encodeId=ce3a512001e2, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：投稿一个多月了，还是一点反应都没有，急死人呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Thu May 21 09:38:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820040, encodeId=7c4782004028, content=评审不专业，给出的意见完全不是行内人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Fri Jun 15 16:07:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=815220, encodeId=116581522060, content=文章水平较高，比较难中！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Sat Jul 09 10:07:00 CST 2011, time=2011-07-09, status=1, ipAttribution=)]
    2021-12-29 Mia

    RUNINGTITLE的撰写方法？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1094996, encodeId=198e1094996f1, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094995, encodeId=8fb51094995bf, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901370, encodeId=78019013e023, content=审稿速度:2.0<br>偏重的研究方向：生物医学工程<br>经验分享：发表几十篇SCI，但这个期刊是印象最不好的，原因如下：<br>从投稿到收到收到最终决定大约两个多月，稿件显示状态一直是"Decision in Process"。<br>最终只得到了拒稿信，没有任何的评审意见。<br>如果是编委觉得稿件不合适，可以用几天，甚至半个月的时间告知作者不适合期刊定位及质量要求，这样不耽误作者转投其它期刊；<br>如果是已经送审，最终连评审意见都不反馈很不专业。<br><br>建议大家还是考虑MP或者PMB，如果被拒，说明文章创新点不够，那么索性就投个三四区一般的期刊，但这个期刊还是要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d382492015, createdName=兰德, createdTime=Mon Nov 23 10:13:54 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512205, encodeId=b210512205d0, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：三个审稿者，一个给了大修，一个给了小修，一个同意直接接收，但要求把文章类型作改为communication。呵呵，不知道机会大不大!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Mon Jun 01 14:16:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512001, encodeId=ce3a512001e2, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：投稿一个多月了，还是一点反应都没有，急死人呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Thu May 21 09:38:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820040, encodeId=7c4782004028, content=评审不专业，给出的意见完全不是行内人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Fri Jun 15 16:07:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=815220, encodeId=116581522060, content=文章水平较高，比较难中！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Sat Jul 09 10:07:00 CST 2011, time=2011-07-09, status=1, ipAttribution=)]
    2021-12-27 桑晒麦拉

    RUNNINGTITLE和TITLE的区别？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1094996, encodeId=198e1094996f1, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094995, encodeId=8fb51094995bf, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901370, encodeId=78019013e023, content=审稿速度:2.0<br>偏重的研究方向：生物医学工程<br>经验分享：发表几十篇SCI，但这个期刊是印象最不好的，原因如下：<br>从投稿到收到收到最终决定大约两个多月，稿件显示状态一直是"Decision in Process"。<br>最终只得到了拒稿信，没有任何的评审意见。<br>如果是编委觉得稿件不合适，可以用几天，甚至半个月的时间告知作者不适合期刊定位及质量要求，这样不耽误作者转投其它期刊；<br>如果是已经送审，最终连评审意见都不反馈很不专业。<br><br>建议大家还是考虑MP或者PMB，如果被拒，说明文章创新点不够，那么索性就投个三四区一般的期刊，但这个期刊还是要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d382492015, createdName=兰德, createdTime=Mon Nov 23 10:13:54 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512205, encodeId=b210512205d0, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：三个审稿者，一个给了大修，一个给了小修，一个同意直接接收，但要求把文章类型作改为communication。呵呵，不知道机会大不大!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Mon Jun 01 14:16:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512001, encodeId=ce3a512001e2, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：投稿一个多月了，还是一点反应都没有，急死人呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Thu May 21 09:38:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820040, encodeId=7c4782004028, content=评审不专业，给出的意见完全不是行内人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Fri Jun 15 16:07:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=815220, encodeId=116581522060, content=文章水平较高，比较难中！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Sat Jul 09 10:07:00 CST 2011, time=2011-07-09, status=1, ipAttribution=)]
    2020-11-23 兰德

    审稿速度:2.0
    偏重的研究方向：生物医学工程
    经验分享：发表几十篇SCI，但这个期刊是印象最不好的，原因如下：
    从投稿到收到收到最终决定大约两个多月，稿件显示状态一直是"Decision in Process"。
    最终只得到了拒稿信，没有任何的评审意见。
    如果是编委觉得稿件不合适，可以用几天，甚至半个月的时间告知作者不适合期刊定位及质量要求，这样不耽误作者转投其它期刊；
    如果是已经送审，最终连评审意见都不反馈很不专业。

    建议大家还是考虑MP或者PMB，如果被拒，说明文章创新点不够，那么索性就投个三四区一般的期刊，但这个期刊还是要慎重。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1094996, encodeId=198e1094996f1, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094995, encodeId=8fb51094995bf, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901370, encodeId=78019013e023, content=审稿速度:2.0<br>偏重的研究方向：生物医学工程<br>经验分享：发表几十篇SCI，但这个期刊是印象最不好的，原因如下：<br>从投稿到收到收到最终决定大约两个多月，稿件显示状态一直是"Decision in Process"。<br>最终只得到了拒稿信，没有任何的评审意见。<br>如果是编委觉得稿件不合适，可以用几天，甚至半个月的时间告知作者不适合期刊定位及质量要求，这样不耽误作者转投其它期刊；<br>如果是已经送审，最终连评审意见都不反馈很不专业。<br><br>建议大家还是考虑MP或者PMB，如果被拒，说明文章创新点不够，那么索性就投个三四区一般的期刊，但这个期刊还是要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d382492015, createdName=兰德, createdTime=Mon Nov 23 10:13:54 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512205, encodeId=b210512205d0, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：三个审稿者，一个给了大修，一个给了小修，一个同意直接接收，但要求把文章类型作改为communication。呵呵，不知道机会大不大!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Mon Jun 01 14:16:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512001, encodeId=ce3a512001e2, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：投稿一个多月了，还是一点反应都没有，急死人呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Thu May 21 09:38:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820040, encodeId=7c4782004028, content=评审不专业，给出的意见完全不是行内人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Fri Jun 15 16:07:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=815220, encodeId=116581522060, content=文章水平较高，比较难中！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Sat Jul 09 10:07:00 CST 2011, time=2011-07-09, status=1, ipAttribution=)]
    2015-06-01 digmed2010

    审稿速度:2.0 | 投稿命中率:5.0
    经验分享：三个审稿者，一个给了大修，一个给了小修，一个同意直接接收，但要求把文章类型作改为communication。呵呵，不知道机会大不大!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1094996, encodeId=198e1094996f1, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094995, encodeId=8fb51094995bf, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901370, encodeId=78019013e023, content=审稿速度:2.0<br>偏重的研究方向：生物医学工程<br>经验分享：发表几十篇SCI，但这个期刊是印象最不好的，原因如下：<br>从投稿到收到收到最终决定大约两个多月，稿件显示状态一直是"Decision in Process"。<br>最终只得到了拒稿信，没有任何的评审意见。<br>如果是编委觉得稿件不合适，可以用几天，甚至半个月的时间告知作者不适合期刊定位及质量要求，这样不耽误作者转投其它期刊；<br>如果是已经送审，最终连评审意见都不反馈很不专业。<br><br>建议大家还是考虑MP或者PMB，如果被拒，说明文章创新点不够，那么索性就投个三四区一般的期刊，但这个期刊还是要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d382492015, createdName=兰德, createdTime=Mon Nov 23 10:13:54 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512205, encodeId=b210512205d0, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：三个审稿者，一个给了大修，一个给了小修，一个同意直接接收，但要求把文章类型作改为communication。呵呵，不知道机会大不大!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Mon Jun 01 14:16:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512001, encodeId=ce3a512001e2, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：投稿一个多月了，还是一点反应都没有，急死人呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Thu May 21 09:38:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820040, encodeId=7c4782004028, content=评审不专业，给出的意见完全不是行内人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Fri Jun 15 16:07:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=815220, encodeId=116581522060, content=文章水平较高，比较难中！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Sat Jul 09 10:07:00 CST 2011, time=2011-07-09, status=1, ipAttribution=)]
    2015-05-21 digmed2010

    审稿速度:3.0 | 投稿命中率:5.0
    经验分享：投稿一个多月了，还是一点反应都没有，急死人呀！

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1094996, encodeId=198e1094996f1, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094995, encodeId=8fb51094995bf, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901370, encodeId=78019013e023, content=审稿速度:2.0<br>偏重的研究方向：生物医学工程<br>经验分享：发表几十篇SCI，但这个期刊是印象最不好的，原因如下：<br>从投稿到收到收到最终决定大约两个多月，稿件显示状态一直是"Decision in Process"。<br>最终只得到了拒稿信，没有任何的评审意见。<br>如果是编委觉得稿件不合适，可以用几天，甚至半个月的时间告知作者不适合期刊定位及质量要求，这样不耽误作者转投其它期刊；<br>如果是已经送审，最终连评审意见都不反馈很不专业。<br><br>建议大家还是考虑MP或者PMB，如果被拒，说明文章创新点不够，那么索性就投个三四区一般的期刊，但这个期刊还是要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d382492015, createdName=兰德, createdTime=Mon Nov 23 10:13:54 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512205, encodeId=b210512205d0, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：三个审稿者，一个给了大修，一个给了小修，一个同意直接接收，但要求把文章类型作改为communication。呵呵，不知道机会大不大!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Mon Jun 01 14:16:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512001, encodeId=ce3a512001e2, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：投稿一个多月了，还是一点反应都没有，急死人呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Thu May 21 09:38:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820040, encodeId=7c4782004028, content=评审不专业，给出的意见完全不是行内人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Fri Jun 15 16:07:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=815220, encodeId=116581522060, content=文章水平较高，比较难中！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Sat Jul 09 10:07:00 CST 2011, time=2011-07-09, status=1, ipAttribution=)]
    2012-06-15 ms9430612511402566

    评审不专业，给出的意见完全不是行内人

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1094996, encodeId=198e1094996f1, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094995, encodeId=8fb51094995bf, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901370, encodeId=78019013e023, content=审稿速度:2.0<br>偏重的研究方向：生物医学工程<br>经验分享：发表几十篇SCI，但这个期刊是印象最不好的，原因如下：<br>从投稿到收到收到最终决定大约两个多月，稿件显示状态一直是"Decision in Process"。<br>最终只得到了拒稿信，没有任何的评审意见。<br>如果是编委觉得稿件不合适，可以用几天，甚至半个月的时间告知作者不适合期刊定位及质量要求，这样不耽误作者转投其它期刊；<br>如果是已经送审，最终连评审意见都不反馈很不专业。<br><br>建议大家还是考虑MP或者PMB，如果被拒，说明文章创新点不够，那么索性就投个三四区一般的期刊，但这个期刊还是要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d382492015, createdName=兰德, createdTime=Mon Nov 23 10:13:54 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512205, encodeId=b210512205d0, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：三个审稿者，一个给了大修，一个给了小修，一个同意直接接收，但要求把文章类型作改为communication。呵呵，不知道机会大不大!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Mon Jun 01 14:16:00 CST 2015, time=2015-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512001, encodeId=ce3a512001e2, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：投稿一个多月了，还是一点反应都没有，急死人呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf111621518, createdName=digmed2010, createdTime=Thu May 21 09:38:00 CST 2015, time=2015-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820040, encodeId=7c4782004028, content=评审不专业，给出的意见完全不是行内人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Fri Jun 15 16:07:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=815220, encodeId=116581522060, content=文章水平较高，比较难中！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Sat Jul 09 10:07:00 CST 2011, time=2011-07-09, status=1, ipAttribution=)]
    2011-07-09 ms5109743545865402

    文章水平较高，比较难中！

    0

共9条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分